Abingdon Health Plc (LON:ABDX – Get Rating)’s share price was down 2.5% during mid-day trading on Monday . The company traded as low as GBX 9.65 ($0.12) and last traded at GBX 9.75 ($0.12). Approximately 348,507 shares were traded during mid-day trading, a decline of 53% from the average daily volume of 736,827 shares. The stock had previously closed at GBX 10 ($0.12).
Abingdon Health Price Performance
The stock’s 50-day moving average price is GBX 10.48 and its 200-day moving average price is GBX 12.16.
Abingdon Health Company Profile
Abingdon Health Plc develops, manufactures, and distributes diagnostic devices worldwide. It offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; Seralite, a rapid lateral flow test for the quantitative measurement of kappa and lambda immunoglobulin free light chains in serum; and AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader.
Featured Articles
- MarketBeat Podcast: Find Investing Opportunities For The Rest of 2022
- The Colgate-Palmolive Growth Outlook BrightensÂ
- Deep Value High Yield Newell Brands Is Ready To BottomÂ
- These Stocks Outperformed Last Time There Was A Recession
- Does Rivian’s Stock Still Have A Future?
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
